PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis (pealkiri)

teaviku laadid

Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Kirjeid leitud 1, kuvan 1 - 1